Delivery Order SPE2DB22D2211-SPE2DB25FRVPT
Award Date
4/18/25
Potential Completion Date
4/21/25
Potential Value
$9.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,177.62 firm fixed-price contract is for the delivery of the diabetes medication MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any specific business category. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,758.60, is for the supply of the diabetes medication Mounjaro 7.5 mg/0.5 ml pen. The delivery order has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,208.59, is for the provision of the diabetes medication Mounjaro (10 mg/0.5 ml pen, 0.5 ml) to support federal medical requirements. The contract is a firm fixed-price delivery order, with a performance period extending through May 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,476.69 firm fixed-price contract is for the supply of the diabetes medication Mounjaro (5 mg/0.5 ml pen). The contract has a performance period through May 12, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mounjaro, a 15 mg/0.5 mL diabetes medication pen, with a ceiling value of $3,117.61 and a period of performance through April 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,441.80, is for the delivery of 4,568,078,553 units of the diabetes medication Mounjaro (12.5 mg/0.5 ml pen, 0.5 ml) with a performance period through April 30, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,632.54, is for the supply of 4.568 million units of the diabetes medication Mounjaro (2.5 mg/0.5 ml pen). The delivery order has an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This award is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,434.34, is for the supply of Mounjaro 10 mg/0.5 ml pens, a medication used to treat diabetes. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. The contract is not designated as a set-aside and was open to full and open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (5 mg/0.5 ml pen). The contract has a ceiling value of $3,446.00 and a period of performance through May 8, 2025. It is a firm-fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mounjaro 10 mg/0.5 ml pens, a diabetes treatment medication. The contract has a firm fixed price, with a ceiling value of $2,708.45, and a period of performance ending on April 18, 2025. This contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a...